Arthritis & Rheumatism

Hepatitis B vaccine less effective in rheumatoid arthritis patients

The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that people with rheumatoid arthritis (RA) are less likely to be protected by hepatitis ...

Diseases, Conditions, Syndromes

Drug prevents passage of HBV during pregnancy

The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), according to a study in the June issue of Clinical Gastroenterology and Hepatology, the official clinical practice journal of the ...

Diseases, Conditions, Syndromes

Lives could be saved with hepatitis C treatment

In a letter to the Medical Journal of Australia published today, a Monash University-led team is asking for hepatitis C virus patients to gain improved access to drugs to prevent liver related deaths.

Diseases, Conditions, Syndromes

Variations in liver cancer attributable to hepatitis virus variations

Significant clinical variations exist among patients with the most common type of liver cancer called hepatocellular carcinoma (HCC), depending on the viral cause of the disease -hepatitis B virus (HBV) or hepatitis C virus ...

Diseases, Conditions, Syndromes

Risk of hepatitis D higher among HIV infected and injection drug users

Researchers from Taiwan determined that individuals with human immunodeficiency virus (HIV) infection or those who inject illicit drugs have a higher risk of becoming infected with the hepatitis D virus (HDV) in that country. ...

Diseases, Conditions, Syndromes

Study details microRNA's role as a double agent during Hep C infection

In the battle between a cell and a virus, either side may resort to subterfuge. Molecular messages, which control the cellular machinery both sides need, are vulnerable to interception or forgery. New research at Rockefeller ...

Diseases, Conditions, Syndromes

WHO urges stepped-up battle against hepatitis B

The world can beat the liver-attacking hepatitis B virus, which results in some 650.000 deaths a year, the World Health Organization said Thursday, releasing its first treatment guidelines for the disease.

Diseases, Conditions, Syndromes

Finding strengths—and weaknesses—in hepatitis C's armor

Using a specially selected library of different hepatitis C viruses, a team of researchers led by Johns Hopkins scientists has identified tiny differences in the pathogens' outer shell proteins that underpin their resistance ...

page 34 from 40